These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23520046)

  • 1. Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.
    Zhu K; van Hilten JJ; Putter H; Marinus J
    Mov Disord; 2013 Jun; 28(6):755-62. PubMed ID: 23520046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG.
    Zhu K; van Hilten JJ; Marinus J
    Parkinsonism Relat Disord; 2014 Sep; 20(9):980-5. PubMed ID: 25024059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hallucinations in Parkinson's disease: cross-sectional study.
    Svetel M; Smiljković T; Pekmezović T; Kostić V
    Acta Neurol Belg; 2012 Mar; 112(1):33-7. PubMed ID: 22427287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up.
    Sinforiani E; Pacchetti C; Zangaglia R; Pasotti C; Manni R; Nappi G
    Mov Disord; 2008 Jul; 23(10):1441-5. PubMed ID: 18512749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease.
    Biglan KM; Holloway RG; McDermott MP; Richard IH;
    Neurology; 2007 Jul; 69(2):187-95. PubMed ID: 17620552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk and course of motor complications in a population-based incident Parkinson's disease cohort.
    Bjornestad A; Forsaa EB; Pedersen KF; Tysnes OB; Larsen JP; Alves G
    Parkinsonism Relat Disord; 2016 Jan; 22():48-53. PubMed ID: 26585090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinations in Parkinson's disease: a follow-up study.
    de Maindreville AD; Fénelon G; Mahieux F
    Mov Disord; 2005 Feb; 20(2):212-7. PubMed ID: 15390044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing an aetiological model of visual hallucinations in Parkinson's disease.
    Gallagher DA; Parkkinen L; O'Sullivan SS; Spratt A; Shah A; Davey CC; Bremner FD; Revesz T; Williams DR; Lees AJ; Schrag A
    Brain; 2011 Nov; 134(Pt 11):3299-309. PubMed ID: 21921019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Course and risk factors for excessive daytime sleepiness in Parkinson's disease.
    Zhu K; van Hilten JJ; Marinus J
    Parkinsonism Relat Disord; 2016 Mar; 24():34-40. PubMed ID: 26846609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of dementia and visual hallucinations in tremor and non-tremor dominant Parkinson's disease.
    Rana AQ; Vaid HM; Edun A; Dogu O; Rana MA
    J Neurol Sci; 2012 Dec; 323(1-2):158-61. PubMed ID: 23062324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.
    Llebaria G; Pagonabarraga J; Martínez-Corral M; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
    Mov Disord; 2010 Dec; 25(16):2785-91. PubMed ID: 20960483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study.
    Postuma RB; Bertrand JA; Montplaisir J; Desjardins C; Vendette M; Rios Romenets S; Panisset M; Gagnon JF
    Mov Disord; 2012 May; 27(6):720-6. PubMed ID: 22322798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease.
    Romenets SR; Gagnon JF; Latreille V; Panniset M; Chouinard S; Montplaisir J; Postuma RB
    Mov Disord; 2012 Jul; 27(8):996-1003. PubMed ID: 22733427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease.
    Hauser RA; McDermott MP; Messing S
    Arch Neurol; 2006 Dec; 63(12):1756-60. PubMed ID: 17172616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What predicts mortality in Parkinson disease?: a prospective population-based long-term study.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
    Neurology; 2010 Oct; 75(14):1270-6. PubMed ID: 20921512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations.
    Santangelo G; Trojano L; Vitale C; Ianniciello M; Amboni M; Grossi D; Barone P
    Mov Disord; 2007 Dec; 22(16):2418-25. PubMed ID: 17894370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease.
    Bronnick K; Emre M; Tekin S; Haugen SB; Aarsland D
    Mov Disord; 2011 Apr; 26(5):824-9. PubMed ID: 21437985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in Parkinson's disease. Relation with motor and non-motor features.
    de Lau LM; Verbaan D; Marinus J; van Hilten JJ
    Parkinsonism Relat Disord; 2014 Jun; 20(6):613-6. PubMed ID: 24679900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.